Candel Therapeutics NASDAQ:CADLCandel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
Sep 29, 2025 Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
Sep 17, 2025 Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer
